Studies
PAC-Man
PACE
PACER
PACIFIC
PACMAN-AMI
PACS
PALACE
PALOMA-3
PAMPer
PANORAMIC
PANTER
PARADIGM
PARADIGM-HF
PARADISE-MI
PARAGON-HF
PARAMEDIC2
PARAMOUNT
PARIS-2
PART
PARTITA
PARTNER
PARTNER 2
PARTNER 3 (1-year follow-up)
PARTNER 3 (5-year follow-up)
PARTNER A
PARTNER B
PASSION
PATCH
PATCH-I
PATCH-Trauma
PATH-HHT
PaTHway (post-hoc analysis)
PATHWAY-2 (spironolactone vs. bisoprolol)
PATHWAY-2 (spironolactone vs. doxazosin)
PATHWAY-2 (spironolactone vs. placebo)
PAUSE-SCD
PCPT
PD vs. IHD in AKI
PEITHO
PEPTIC
PermiT (post-hoc analysis, high-risk)
PermiT (post-hoc analysis, low-risk)
PEXIVAS (corticosteroids)
PEXIVAS (plasmapheresis)
PHARLAP
Phentermine/topiramate for obesity in adolescents (mid-dose)
Phentermine/topiramate for obesity in adolescents (top-dose)
PHOENIX
PICASSo
PINETREE
PIONEER AF-PCI (low-dose rivaroxaban)
PIONEER AF-PCI (very low-dose rivaroxaban)
PIONEER-HF
Pivetta
PLACIDE
PlasmAr
PlasmAr Study
Platinum-doublet in MPM
PLATO
PLUS
PMB-CROS
PneumA
POEM for achalasia
POETYK PSO-1 (deucravacitinib vs. apremilast)
POETYK PSO-1 (deucravacitinib vs. placebo)
POETYK PSO-2 (deucravacitinib vs. apremilast)
POETYK PSO-2 (deucravacitinib vs. placebo)
POINT
POISE 1
POISE-2 (aspirin)
POISE-2 (clonidine)
POISE-3
POLAR
POLARIX
POP-UP
POPLAR
PORTEC-1
PORTEC-2
PORTEC-3
PORTEC-3 (post-hoc analysis)
POSEIDON (chemotherapy plus durvalumab and tremelimumab)
POSEIDON (chemotherapy plus durvalumab)
PRAMI
PRASE
PRECISE
PREDICT
Prednisone for recurrent implantation failure
PregnAnZI-2
PREOPTI-DAM
PREOXI
PREOXYFLOW
PREP-IT (closed fracture)
PREP-IT (open fracture)
PREPARE
PREPARE II
PREPIC
PREPIC 2
PRESERVE (acetylcysteine)
PRESERVE (sodium bicarbonate)
Pressure support vs. CPAP as SBT in children
PREV-HAP
PReVENT (acute respiratory distress syndrome)
PREVENT (mechanical thromboprophylaxis)
PreVent (tracheal intubation)
PREVENT CLOT
PRIMA
PRIMAL
PRIME Care
PRIZE
PRO-HF
PROARRAY
PROBESE
Probiotics for AOM
Probiotics in Septic AKI
PROCAMIO
PROCESS (herpes zoster)
ProCESS (septic shock)
PROCOAG
PRODIGE 4 ACCORD 11
PRoFESS
PROFILE
PROGRESS
PROGRESS (atogepant 30 mg BID)
PROGRESS (atogepant 60 mg OD)
PROLONG
PROMINENT
PROMIS-I
PROMIS-II
ProMISe
PROMOTE
Prone positioning in hypoxemic ARF
Prone ventilation in severe ARDS
Prone-Supine
Prone-Supine II
PRONECMO
PROPEL
PROPHY-VAP
PROPPR
Propranolol in severe TBI
PRORATA
PROSEVA
PROSPECT
PROTECHT
PROTECT
PROTECT AF
PROTECTION
PROVE IT-TIMI 22
PROWESS
PROWESS-SHOCK
Psilocybin in AUD
Psilocybin in MDD
PSP
PSYLECT (double active vs. double sham)
PSYLECT (double active vs. tDCS only)
PSYLECT (tDCS only vs. double sham)
Pulmonary artery catheterization in acute lung injury
Pulmonary artery catheterization in high-risk surgery
PULSAR (high-dose sotatercept)
PULSAR (low-dose sotatercept)
PULSE-MI
PUNCH CD3 (secondary analysis)
PURPOSE 1 (F/TAF vs. F/TDF)
PURPOSE 1 (lenacapavir vs. F/TDF)
PUSH-AHF